| |
Instructions for Authors
General Information
European Urology, ''The Platinum Journal,'' published continuously
since 1975, is an international peer-reviewed journal devoted to urology and related sciences and is published monthly. European Urology
is the official journal of the European Association of Urology (EAU), a scientific society with 9,000 members from 120 countries worldwide.
European Urology is available both in print and online and reaches over 20,000 readers.
European Urology's 2008 impact factor is
6.512. The impact factor is a measure of the citation rate per article,
and is calculated by dividing 1 year's worth of citations
to a journal's articles published in the previous 2 years
by the number of major articles [e.g., research papers, reviews] published
by that journal in those 2 years.
European Urology's acceptance rate is approximately 18% of the nearly 2000 solicited and unsolicited
manuscripts it receives annually; its average time from submission to first editorial decision is approximately 16 days and the average
time from submission to inclusion in Medline is 160 days. The Editor-in-Chief of European Urology is Francesco Montorsi.
Each month
European Urology publishes a wide variety of articles in all areas of urology and related sciences. The journal publishes review articles,
original articles, Surgery in Motion articles with accompanying DVD editorials, editorial comments, interviews, debates, Words of Wisdom,
Letters to the Editor, and case reports.
Review articles, editorials and related articles, and letters to the editor can be read
in full text without charge at http://www.europeanurology.com and http://www.urosource.com.
EU-ACME accredited
questions are included in every issue of European Urology and can be answered at http://www.eu-acme.org/europeanurology.
Manuscripts should be submitted online via the European Urology online manuscript submission and review system at http://ees.elsevier.com/eururol
.
Statements in articles or opinions expressed by any contributor in any article are not the responsibility of the editors or the
publishers. The publisher is not responsible for the loss of manuscripts through circumstances beyond its control.
Accepted manuscripts
will be copyedited to make sure they conform to the journal's style. The final version of the manuscript following copyediting will be
sent back to the author only if specific queries need clarification.
Editorial Office Contact Information
Questions regarding
manuscript submission may be sent to:
European Urology Editorial Office
Ms. Cathy Pierce, Editorial Office Manager or
Ms.
Kerri James, Editorial Office Assistant
Via Stamira d'Ancona 20
20127 Milan Italy
Telephone: +39 02 2643 6438
Telephone:
+39 02 2643 6432
Fax: +39 02 2643 6450
E-mail: european.urology@hsr.it
Editorial Policy
Authorship
Criteria and Contributions and Authorship
Form
Completion and inclusion of the Authorship Responsibility, Financial Disclosure
and Acknowledgment Form is an obligatory step of the submission process for Original Articles, Review Articles and Surgery in Motion
articles. A standard disclosure stating conflicts of interests, if any, can be uploaded for letters to the editor, editorials, words
of wisdom and case reports.
If the form is not completed as instructed below, the manuscript will not be considered for peer review.
The corresponding author must submit the above mentioned completed form on behalf of all coauthors, if any. Download form here:
authorship form.
The
corresponding author must take responsibility for the integrity of the work as a whole, from inception to published article. Each collaborating
author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authorship
credit should be based on: substantial contributions to conception and design, acquisition of data, analysis and interpretation of data,
drafting of the article or revising it critically for
important intellectual content, statistical analysis, obtaining funding, administrative,
technical or material support, supervision and any other specifics to be declared at publication. The corresponding authors is obliged
to indicate the coauthors contribution to the manuscript in the appropriate field in the said form.
Each coauthor's specific contribution
for reports of
original data and systematic reviews will be
included with the published manuscript.
Each field may include more than
one author.
Role of the Corresponding Author
The corresponding author will serve on behalf of all
coauthors as the primary
correspondent with the
editorial office during the submission and review
process. If the manuscript is accepted, the corresponding
author
will review an edited typescript
and proof and will be identified as the corresponding
author in the published article. The corresponding
author is responsible for ensuring that all information
included in the Authorship Responsibility,
Financial Disclosure and Funding Support
form
and the Acknowledgment section, if any, is complete
and has been agreed on by all authors.
''Acknowledgment'' is the general term
for the list of
contributions, credits, and other information included at
the end of the text of a manuscript before the references.
Group Authorship
If authorship is attributed to a group (either solely
or in addition to one or more individual authors),
all members of the group must meet the full
criteria and requirements for authorship as
described above. If that is not the case, a group
must designate one or more individuals as authors
or members of a writing group who meet full
authorship criteria and requirements. Other
group
members who are not authors may be listed in an
Acknowledgment.
Conflicts of Interest and Financial Disclosures
A conflict of interest may exist when an author (or
the author's institution or employer) has financial or
personal relationships or
affiliations that could
influence (or bias) the author's decisions, work, or
manuscript.
Authors are expected to provide detailed
information
about all relevant financial interests
and relationships or financial conflicts (e.g.,
employment/affiliation, grants or
funding, consultancies,
honoraria, stock ownership or options,
expert testimony, royalties, or patents filed,
received, or pending),
particularly those present
at the time the research was conducted and
through publication, as well as other financial
interests (such
as patent applications in preparation),
that represent potential future financial
gain.
For example, authors of a manuscript about
prostate
cancer should report all financial relationships
they have with all manufacturers of
products used in the management of prostate
cancer, not only those relationships with companies
whose specific products are mentioned in the
manuscript.
Although many universities
and other institutions
have established policies and thresholds for reporting
financial interests and other conflicts of interest,
European
Urology requires complete disclosure of
all relevant financial relationships and potential
financial conflicts of interest, regardless
of amount
or value.
All disclosures of any potential conflicts of interest,
including specific financial interests and relationships
and affiliations (other than those affiliations
listed in the title page of the manuscript) relevant to
the subject of their manuscript
will be disclosed
by the corresponding author on behalf of each
coauthor, if any, as part of the submission process.
Likewise, authors
without conflicts of interest, will
be requested to state so as part of the submission
process.
If authors are uncertain about what
constitutes a
relevant financial interest or relationship, they
should contact the editorial office.
Failure to include this information
in the manuscript
will prohibit commencement of the review
process of the manuscript.
For all accepted manuscripts, each author's
disclosures
of conflicts of interest and relevant financial
interests and affiliations and declarations of no such
interests will be
published.
The policy requesting disclosure of conflicts of interest
applies for all manuscript submissions. If an
author's disclosure
of potential conflicts of interest
is determined to be inaccurate or incomplete after
publication, a correction will be published to
rectify
the original published disclosure statement.
Authors are also required to report detailed information
regarding all financial
and material support
for the research and work, including but not limited
to grant support, funding sources, and provision of
equipment
and supplies as part of the submission
process. For all accepted manuscripts, each author's
source of funding will be published.
Funding/Support
and Role of Sponsor
All financial and material support for the research
and work will be requested to be clearly and completely
identified as part of the submission process.
The specific role of the funding organization or
sponsor in each of the following should
be specified:
''design and conduct of the study; collection, management,
analysis, and interpretation of the data;
and preparation, review,
or approval of the manuscript.''
The corresponding author is responsible for
acknowledging this on the authorship form at the
time of
submission.
Data Access and Responsibility
For all reports (regardless of funding source) containing
original data, at
least one named author (e.g.,
the principal investigator) who is independent of any
commercial funder should indicate that she or he
''had full access to all the data in the study and takes
responsibility for the integrity of the data and the accuracy
of the data analysis.''
This exact statement will be
requested as part of the submission process. Modified
statements or generic statements indicating
that all
authors had such access are not acceptable.
Duplicate/Previous Publication or Submission
Manuscripts are considered with
the understanding
that they have not been published previously in
print or electronic format and are not under consideration
by another
publication or electronic
medium. Copies of related or possibly duplicative
materials (ie, those containing substantially similar
content
or using the same or similar data) that have
been previously published or are under consideration
elsewhere must be provided at the time
of
manuscript submission.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations,
formal review and approval, or review and waiver,
by an appropriate institutional review board or
ethics committee is required and should
be
described in the Methods section. For those investigators
who do not have formal ethics review
committees, the principles outlined
in the Declaration
of Helsinki should be followed. For investigations
of human subjects, state in the Methods
section the manner in which
informed consent
was obtained from the study participants (ie, oral
or written).
Personal Communications and Unpublished Data
A signed statement of permission should be
included from each individual identified as a source
of information in a personal communication
or as a
source for unpublished data, and the date of communication
and whether the communication was
written or oral should be specified.
Previous Presentation or Release of Information
A complete report following presentation at a meeting
or publication of preliminary
findings elsewhere
(e.g., an abstract) is eligible for consideration for
publication.
Unauthorized Use
Published manuscripts
become the permanent
property of the EAU and may not be published elsewhere
in whole or in part without written permission.
Unauthorized
use of the European Urology
name, logo, or any content for commercial purposes
or to promote commercial goods and services (in any
format,
including print, video, audio, and digital) is
not permitted by the EAU.
Editorial Review and Publication
Authors will be
sent notifications of the receipt
of manuscripts and editorial decisions by e-mail.
During the review process, authors can check the
status of their submitted manuscript via the online
manuscript submission and review system.
Editorial and Peer Review
All submitted manuscripts are reviewed initially by
the European Urology Editor-in-Chief and Associate
Editors. Manuscripts submitted
for the Surgery in
Motion section will also undergo peer review, supervised
by the Editor-in-Chief and the Surgery Editor
and must be
submitted along with the accompanying
DVD (please see ''Types of Articles'' section
below).
Manuscripts are evaluated according to
the following
criteria: material is original and timely, writing
is clear, study methods are appropriate, data are
valid, conclusions
are reasonable and supported by
the data, information is important, and the topic
has general interest for urologists. From these
basic
criteria, the editors decide whether a manuscript
reaches a priority score to justify peer
review. Manuscripts with insufficient priority
for
publication are rejected promptly. Manuscripts
which have not be straight rejected are sent to
expert consultants for peer review.
Although rare,
it is possible for an exceptional manuscript to be
accepted upon submission.
Manuscripts considered to be of interest
by the
editors will be peer reviewed by internationally
recognized experts on the subject. Each manuscript
is sent to 6-10 reviewers.
When necessary, a biostatistician
will also review manuscripts.
Reviewers are matched to the paper according to
their expertise. Our
reviewer database is constantly
being updated to ensure the reviewer profile
matches that of the topic being discussed in the
manuscript.
We welcome suggestions for reviewers
from the author though these recommendations
may or may not be considered.
Reviewer Reports
Reviewers are asked to evaluate whether the manuscript:
- Is original
- Is methodologically sound
- Follows appropriate
ethical guidelines
- Has results that are clearly presented and support
the conclusions
- Correctly references previous
relevant work
- Is aimed at the journal's target readership
Reviewers are not expected to correct or copyedit
manuscripts.
Language correction is not part of the
peer-review process.
Reviewers are allotted 14 days to complete their
reviews. The reviewers
are not blinded to the names
of the authors or the institution from which the
manuscripts have been submitted.
Final Editorial
Decision
The final decision to accept, revise, or reject a manuscript
is made by the Editor-in-Chief after carefully
considering
the opinion of the Associate Editor(s)
handling that particular manuscript. The decision is
sent to the author along with any recommendations
made by the reviewers and editors.
Publication
Prior to submitting a manuscript to European Urology,
authors must ensure
that each requirement
listed below is met. Manuscripts that do not meet
these requirements will be returned to the author
without review.
Editing
The corresponding author is responsible for ensuring the quality of the language and grammar of the manuscript and
that the journal manuscript requirements have been met. Authors are encouraged to have the manuscript professionally copyedited before
submitting. European Urology employs Dragonfly Editing for the final copyediting of accepted manuscripts before publication.
Those
who would like to utilize their services are free to contact: Dragonfly Editorial at http://www.dragonflyeditorial.com
Accepted manuscripts are edited in accordance with
the journal in-house style. Authors are responsible
for all statements made in their
work, including
changes made during editing and production that
are authorized by the corresponding author.
Corrections
Requests to publish corrections should be sent to the
editorial office. Corrections are reviewed by editors
and authors, published promptly,
and linked online
to the original article.
Offprints
Offprints may be ordered when the edited typescript
is sent for approval
to the corresponding author. 25
free offprints are shipped 2 weeks after publication.
Additional copies (minimum 100) can be ordered
at
prices quoted on the order form that will be sent
with the acknowledgment letter.
Types of Articles
Original articles
These manuscripts typically report on basic and
translational research, epidemiology, pathophysiology, diagnosis, medical or surgical
treatment,
and minimally invasive therapy related to urologic
diseases.
Each manuscript should clearly state an objective or
hypothesis;
the design and methods (including the
study setting and dates, patients or participants
with inclusion and exclusion criteria and/or
participation
or response rates, or data sources, and how
these were selected for the study); the essential
features of any interventions;
the main outcome
measures; the main results of the study; a discussion
section placing the results in context with the
published literature
and addressing study limitations;
and the conclusions. Data included in
research reports should be as timely and current
as possible.
The format of the original article should be as follows:
Abstract
Provide a structured abstract no longer than 300
words
with the following sections: Background;
Objective; Design, Setting, and Participants; Intervention
(include if there are any); Measurements;
Results and Limitations; Conclusions.
For brevity, parts of the abstract may be written as
phrases rather than complete sentences.
Each section should include the following content
(see abstract structure details below):
- Background: The abstract should begin
with a
sentence or two explaining the clinical (or other)
importance of the study question.
- Objective: State the precise objective
or study
question addressed in the manuscript (e.g., ''To
determine whether. . .''). If more than one objective
is addressed, the main
objective should be
indicated and only key secondary objectives
stated.
- Design, Setting, and Participants: Describe the
basic
design of the study. State the years of
the study and the duration of follow-up. Describe
the study setting to assist readers to determine
the applicability of the report to other circumstances,
for example, general community, a
primary care or referral center, private or
institutional
practice, or ambulatory or hospitalized
care. State the clinical disorders, important
eligibility criteria, and key sociodemographic
features of patients. The numbers of participants
and how they were selected should be provided.
In follow-up studies, the proportion
of participants
who completed the study must be indicated.
In intervention studies, the number of
patients withdrawn because of adverse
effects
should be given. For selection procedures, these
terms should be used, if appropriate: random
sample (where random refers to
a formal, randomized
selection in which all eligible individuals
have a fixed and usually equal chance of selection);
population-based
sample; referred sample;
consecutive sample; volunteer sample; convenience
sample.
- Intervention(s): The essential features of
any
interventions (surgical or medical) should be
described. The nonproprietary drug or device
names should be used unless the specific
trade
name is essential to the study.
- Measurements: Indicate the primary and secondary
study outcome measurement(s).
- Results
and Limitations: The main outcomes of
the study should be reported and quantified.
Complications or sequelae of the interventions
used must be detailed. Particular attention must
be given to statistical analysis. All randomized
controlled trials should include the results
of
intention-to-treat analysis, and all surveys should
include response rates. Limitations of the study
should be acknowledged.
- Conclusions: Provide only conclusions of the
study directly supported by the results, along
with implications for clinical practice,
avoiding
speculation and overgeneralization. Indicate
whether additional study is required before
the information should be used in usual
clinical settings. Give equal emphasis to positive
and negative findings of equal scientific
merit.
- Trial Registration: For
clinical trials, the name of
the trial registry, registration number, and URL of
the registry must be included.
See example
of a structured abstract.
Text
The text of the manuscript should be divided
as follows: Introduction; Material (Patients) and
Methods; Results; Discussion;
Conclusions.
- Number of references should be limited to 30.
- Maximum word count is 2,500, including the
abstract but
not including the references, tables,
figures, or legends.
Take Home Message
Two or three sentences (no more than
40 words)
summarizing the main message expressed in the
article must be uploaded as a separate file.
Ethical Considerations and
Registration of Clinical Trials
Trial Registration: As a member of the International
Committee of Medical Journal Editors (ICMJE),
European
Urology requires, as a condition of consideration
for publication, registration of all trials in a
public trials registry that
is acceptable to the ICMJE
and that requires the minimum registration data set
as described by the ICMJE.
Acceptable trial registries
include the following:
http://www.actr.org.au
http://www.clinicaltrials.gov
http://isrctn.org
http://www.trialregister.nl/trialreg/index.asp
http://www.umin.ac.jp/ctr
For this purpose, a
clinical trial is any study that
prospectively assigns human subjects to intervention
or comparison groups to evaluate the cause and-
effect relationship between a medical/surgical
intervention and a health outcome. All clinical
trials, regardless of when they were completed,
and secondary analyses of original clinical trials
must be registered before submission of a
manuscript based on the trial. For clinical
trials
starting patient enrollment after July 2005, trials
must be registered before onset of enrollment.
Studies designed for other
purposes, such as to
study pharmacokinetics or major toxicity (e.g.,
phase 1 trials), are exempt. Trial registry name,
registration identification
number, and the URL for
the registry should be included at the end of
abstract.
CONSORT
Flow Diagram and Checklist: Manuscripts
reporting the results of randomized controlled trials
should include the CONSORT
flow diagram showing
the progress of patients throughout the trial. The
CONSORT
checklist also should be completed and submitted with the manuscript and can be found on
http://www.europeanurology.com.
Review Articles
These are reviews that systematically find, select,
critique, and synthesize evidence relevant to well defined
questions about diagnosis, therapy, and
prognosis. Review articles are in principle solicited
by the editorial board. Authors who would
like to submit
unsolicited review articles should first write to the editorial
office describing the content of the review article they
wish
to submit. Review articles should not be submitted
in full without prior approval from the editors.
The format of the review
article should be as follows:
Abstract
Provide a structured abstract no longer than
300 words with the following sections:
Context,
Objective, Evidence Acquisition, Evidence Synthesis,
Conclusion (see abstract structure details below.)
- Context: Include
one or two sentences describing
the clinical question or issue and its importance in
clinical practice or public health.
- Objective:
State the precise primary objective of
the review. Indicate whether the review emphasizes
factors such as cause, diagnosis, prognosis,
therapy, or prevention and include information
about the specific population, intervention, exposure,
and tests or outcomes that are
being
reviewed.
- Evidence Acquisition: Describe the data sources
used, including the search strategies, years
searched, and other
sources of material, such as
subsequent reference searches of retrieved articles.
Methods used for quality assessment and
inclusion of
identified articles should be explained.
- Evidence Synthesis: The major findings of the
review of the clinical issue or topic
should be
addressed in an evidence-based, objective, and
balanced fashion, with the highest quality evidence
available receiving the
greatest emphasis.
- Conclusions: The conclusions should clearly
answer the questions posed if applicable, be based
on available
evidence, and emphasize how clinicians
should apply current knowledge.
See example of a structured abstract.
Text
The text of the manuscript should be divided as
follows: Introduction, Evidence Acquisition,
Evidence
Synthesis, Conclusions.
- Maximum word count is 4000, including the
abstract but not including the references, tables,
figures, or legends.
- Number of references should be limited to 50.
Take Home Message
Two or three sentences
(no more than 40 words)
summarizing the main message expressed in the
article must be uploaded as a separate file.
Surgery in
Motion
Authors are welcome to submit manuscripts describing
particular surgical techniques. In addition to
describing the technique
in detail, early and long term
results and complications must be reported as
well. Mandatory requirements include a minimum number
of
10 patients who have undergone the procedure in
discussion and with a minimum 1-year follow-up of all
patients. Authors are encouraged
to include professional
sketches describing the key steps of the surgical
procedures. Examples of suitable sketches can
found on see Stolzenburg.
In addition, a professional DVD illustrating the surgical technique should
accompany the article.
Sending the files through our dedicated FTP server is preferred. Please contact the editorial office at: european.urology@hsr.it
for uploading instructions.
If you would prefer to send the video via post, digital files (miniDV, DV, DVD, DVCAM, DVCPRO) are the
preferred format, but the journal also accepts Betacam, Digital 8 or MPEG2, MPEG4, and Quicktime Files. The duration of the video should
be 10 to 15 minutes, and audio should be provided as well. Please send 3 copies of the DVD to the editorial office.
The format
of these manuscripts should follow the
guidelines for original articles with the exception of
the abstract.
Abstract
Provide
a structured abstract no longer than 300
words with the following sections: Background;
Objective; Design, Setting, and Participants;
Surgical
Procedure; Measurements; Results and Limitations;
Conclusions.
For brevity, parts of the abstract may be written as
phrases
rather than complete sentences.
- Background: The abstract should begin with a
sentence or two explaining the importance of
and
the need for the described surgical procedure.
- Objective: State the precise objective addressed in
the manuscript (e.g., ''To
show the efficacy and
safety of. . .'').
- Design, Setting, and Participants: Describe the
basic design of the study. State the
years of
the study and the duration of follow-up. Describe
the study setting to assist readers to determine the
applicability of the
report to other circumstances,
for example, office-based/private urologists vs.
hospital/academic urologists. State the number,
clinical
characteristics, and important inclusion/
exclusion criteria of patients.
- Surgical Procedure: The essential features of the
operation should be described. The nonproprietary
device names should be used unless the
specific trade name is essential to the study.
- Measurements: Indicate the primary and secondary
study outcome measurement(s).
- Results and Limitations: The main outcomes
of
the study should be reported and quantified.
Complications or sequelae of the procedure used
must be detailed. Limitations of the
study must be
acknowledged.
- Conclusions: Provide only conclusions of the
study directly supported by the results, along
with
implications for clinical practice, avoiding
speculation and overgeneralization. Indicate
whether additional study is required before
the
information should be used in usual clinical
settings. Give equal emphasis to positive and
negative findings of equal scientific
merit.
Examples of how a Surgery in Motion abstract
should be structured see example of a structured abstract.
Text
The text of the manuscript should be divided as
follows: Introduction; Patients and Methods
(a
sub-section called ''Surgical Technique'' must be
included in this section); Results; Discussion; Conclusions.
- Number of
references should be limited to 30.
- Maximum word count is 3000, including the
abstract but not including the references, tables,
figures, or legends.
Take Home Message
Two or three sentences (no more than 40 words)
summarizing the main message
expressed in the
article must be uploaded as a separate file. This text
will be used on the contents page, and it should
stimulate the
reader to read through the full text
of the article.
Case Reports
Case reports are only considered for acceptance and
publication if submitted as ''Case Study of the
Month.''
Case Study of the Month
Authors are welcome to submit case reports
with
high educational content for possible publication as
a ''Case Study of the Month.'' Each issue will include
one such case. The text
must include an unstructured
abstract (100-word limit), the case report, a
discussion, and up to 10 references. The text must
be accompanied
by four to six figures, which will be
published on the front cover of the journal. At the
end of the case report, the author must also
include
one EU-ACME question related to the information
provided in the text. Four possible answers must be
provided as well, with only
one of them being correct.
The correct answer must be explained in a
short text of no more than 50 words; up to three
references are
allowed to support this explanation.
The text of the ''Case Study of the Month'' should be
no longer than 1000 words (including abstract
but
not including references, figures, tables, and legends).
The question and answers will not be printed in
the journal but will be
available on the website
http://www.eu-acme.org/europeanurology/ .
Editorials
These are commentaries on current
topics or on
papers published elsewhere in the issue. Word
count limit is 1500 and 10 references are allowed.
All editorials are solicited
by the editors and
should not be submitted without prior written
approval.
Reviews of books, journals, and new media are solicited
by the editor.
Letters to the Editor
Letters to the Editor are considered for publication
(subject to editing and abridgment)
provided
they do not contain material that has been
submitted or published elsewhere. They must
be submitted online via Editorial Manager
http://ees.elsevier.com/eururol .
Please note that European Urology considers two
different types of Letters to the Editor.
Letters to the Editor about a recent journal article
Letters referring to a recent journal article must be
received within
three months of its publication.
For example, a letter referring to an article published
in the January issue must be submitted
online
no later than March 31st. Letters submitted
after the allowed time will not be considered. The
text, not including references, must not
exceed 500
words. A maximum of three authors and five references
are allowed. Neither tables nor figures are
allowed.
Letters
to the Editor NOT referring to a recent journal
Article
Original research that is of interest but does not
fulfill all the requirements
needed for publication
as a full-length manuscript can be submitted as a
letter to the editor. The letter must have a title and a
maximum
of three authors.
The text, not including references, tables, figures or legends must not exceed 500 words. No more than five references
and either one table or one figure are allowed.
Residents Corner Articles
This section is reserved for original articles
for which the first author is a resident in training. Authors should provide official certification of resident status when submitting
an article for this specific section of the journal. Please mention that you would like to make your article eligible for the Resident's
Corner section in the "Enter Comments" field when submitting. Manuscripts must adhere to the instructions for author for Original Articles
(see above). The two best papers published in this section during the calendar year will be awarded a special prize during the European
Urological Association
annual meeting.
Fast-track submission
For new findings of sufficient importance to justify
accelerated
review and publication, a fast-track submission
process for original articles is available. In
the submission letter, authors should
explicitly
request this option and provide credit card information
(number, expiration date, and name as it
appears on the card). If
the editors agree that the
manuscript is worthy of fast-track publication, the
fee of 300 Euros will be automatically charged to
the
credit card. If accepted for fast-track submission,
an article will be reviewed within 72 hours (otherwise,
authors will be informed
that the paper will be
handled within the normal peer-review process). If
accepted, a fast-track submission will appear in
the first
available issue of the journal.
EU-ACME articles
Three articles per issue are selected by the Editor-in-
Chief as EU-ACME
articles. These articles are
highlighted as such in the table of contents of
both the printed and online version of the journal
european
urology 53 228 ( 2 0 0 8 ) 221 230
and on the first page of the article. Upon request,
authors must provide six EU-ACME questions
based
on the information provided in the article
with the submission. Four possible answers must
be provided for each question, with only one
of
them being correct. The correct answer should be
explained in text limited to 50 words; up to three
references are allowed to support
this explanation.
(Specifically dedicated instructions for authors for
these questions and answers will be provided.) The
questions and
answers will not be printed in
the journal but will be available on the website
http://www.eu-acme.org/europeanurology/
.
Manuscript Preparation and Submission Requirements
Platinum Priority Articles
As of January 2009, European
Urology has been publishing "Platinum Priorities" articles. These articles are specifically selected by the Editor-in-Chief at time of
acceptance.
Collaborative Review Articles
The Collaborative Review Articles are solicited by the Editor and are coordinated
in collaboration with the Editorial Office. Collaborative Review Articles are submitted by invitation only.
Manuscript Submission
Original manuscripts written in English should
be submitted through the web site of our
online submission system, Editorial Manager
(http://ees.elsevier.com/eururol
), in
Word, WordPerfect, or LaTeX formats for text and
EPS or TIFF for illustrations. Authors may also check
the status of submitted
articles at this site. At the
time of submission, complete contact information
(postal/mail address, e-mail address, telephone and
fax
numbers) for the corresponding author is
required. First and last names, e-mail addresses,
and institutional affiliations of all coauthors
are
also required. Manuscripts submitted through the
online system should not also be submitted by mail
or e-mail. Once the manuscript
is submitted online,
the corresponding author will receive a manuscript
number and will be able to follow the status of the
manuscript
through the online system.
Manuscript Components
Authors submitting manuscripts which require thorough statistical analysis
are asked to have the manuscript reviewed by a professional statistician before submission.
Include a title page, abstract, text,
references, and as
appropriate, figure legends, tables, and figures, take
home message (for original and review articles) and
authorship
form (authorship form can be downloaded
at authorship
form).
Start each of these sections on a new page, numbered
consecutively, beginning with the title page. Please
check
the instructions per article type listed above.
Manuscript File Formats
For submission and review, acceptable manuscript
file formats include Word, WordPerfect, EPS, Text,
Postscript, or RTF format. Use 12-point font
size, double-space text, and leave right
margins
unjustified with margins of at least 2.5 cm. Each
page should be numbered in the upper right corner,
beginning on p. 2. Add continuous
line numbering.
Title Page
The title page should include a word count for
the text and abstract separately. Authors full
names, highest academic degrees, and affiliations
should also be included (see list below). If an
author s affiliation has changed since
the work
was done, the new affiliation also should be listed.
For indexing purposes, 3 10 key words should
be supplied in alphabetical
order (see example
below)
- Title
- Authors (first name and initials followed by
surname, e.g., Juan X. Alvarez)
- Affiliations
(if multiple affiliations are listed,
indicate with lowercase letter footnotes following
the respective authors names)
- Contact
information for corresponding author,
including full mailing address, telephone number,
fax number, and e-mail address
- For indexing
purposes, 3 10 keywords should be
supplied (in alphabetical order) as follows: Keywords
Benign prostatic hyperplasia; Doxazosin;
Lower
urinary tract symptoms
- Word count of text: include the abstract but not
the references in this count
- Word count of
the abstract (please remember Abstracts cannot exceed 300 words)
Abstracts
Include a structured abstract of no
more than 300
words for original, review and surgery in motion
articles. (See instructions above for preparing structured
abstracts.)
Abstracts are not required for editorials.
No information should be reported in the
abstract that does not appear in the text of the
manuscript.
Headings
Do not use automatically generated numbering or
bulleting systems or hidden text (e.g., for headings,
references, footnotes, lists).
Units of Measurement
Units of measurements must conform to the
Systeme International (SI):
year(s), yr; month(s),
mo; days, d; hours, h; minutes, min; seconds, s;
grams, g; liters, l; meters, m; sample size, n; degrees
of freedom,
df; standard error of the mean, SE;
standard deviation, SD; probability, p.
Numerals and Abbreviations
Use numerals for
all values greater than ten and
those followed by a unit; otherwise, spell out (e.g.,
18 patients, 0.8 g/ml, 47%, 37 8C, six cases).
Spell out
numbers at the beginning of a sentence. Abbreviations
must be defined at first use in each of the
following: text, tables,
and figure legends.
Acknowledgments
The ``Acknowledgments section is the general term
for the list of contributions, credits,
and other information
included at the end of the text of a manuscript
but before the references. Authors should
obtain written permission
to include the names of
individuals in the Acknowledgment section.
References
In the text, references should be cited
in numerical
order, with citation numbers placed in square brackets.
Personal communications (pers. comm.) and unpublished
data (unpubl.
data) are mentioned only in the
text: (pers. comm., A. Brown, Ithaca, NewYork, USA).
Each reference number should correspond to a
single
published source.
List all authors up to six; for more than six authors
list the first three followed by ``et al.
Use
Index Medicus abbreviations for journals.
Provide full page ranges, using the abbreviated format
shown below.
[1] MacDonald R, Fink
HA, Huckabay C, Monga M,
Wilt TJ. Botulinum toxin for treatment of urinary
incontinence due to detrusor overactivity:
a systematic review
of effectiveness and adverse
effects. Spinal Cord 2007;45:535—41.
[2] Filocamo M, Li Marzi V, Del Popolo G, et al.
Pharmacologic
treatment in postprostatectomy
stress urinary incontinence. Eur Urol 2007;51:1559—64.
[3] Hatzimouratidis K, Hatzichristou
D. Testosterone
and erectile function: an unresolved enigma.
Eur Urol 2007;52:26—8.
Book
[1] King RC, Stansfield WD. A dictionary
of genetics,
ed. 3. New York: Oxford University Press; 2002.
Book chapter
[1] Hunskaar S, Burgio K, Diokno AC, Herzog AR,
Hjalmas
K, Lapitan MC. Epidemiology and
natural history of urinary incontinence. In:
Abrams P, Cardoza L, Khoury S, Wein A, editors.
Incontinence:
2nd International Consultation on
Incontinence, ed. 2. Plymouth, UK: Health Publications,
2002. p. 165—201.
Thesis or Dissertation
[1] Kato H. Neuroendocrine cells: their effect on the
development of benign prostatic hyperplasia.
Ph.D. diss. [MS thesis], University
of Tokyo
Medical School, Tokyo, 1997.
Tables
- Compose tables in a word-processing program; do
not insert as graphic
elements. Number tables
with Arabic numerals in the order they appear in
the text. Place each table on a separate page.
- Provide
a title at the top of each table.
- Explain abbreviations and include any other
comments in a note at the bottom of each table.
Figures
- Figures must supplement, not duplicate, the
tables and text.
- Illustrations must clearly convey
their message
and be of high quality and sufficient size and clarity
(especially lettering, arrows, and data points) to be
interpretable
when reduced for publication.
- Number figures with Arabic numerals in the order
they appear in the text.
- Provide a separate
list of figure legends at the
end of the text; do not place legends on the
figures.
- Do not embed artwork within the text; figures
should be supplied as separate files.
- Guidelines for submitting figures in an electronic
format can be found at http://www.elsevier.com/wps/find/authors.authors/authorartworkinstructions/ under Artwork Instructions.
Manuscript Checklist
Prior to submitting a manuscript to European Urology,
authors must ensure that each requirement
listed above is met. Manuscripts that do not meet
these requirements will be returned to the
author
without review. |
| |
|
